AJP - Endocrinology and Metabolism, Vol 263, Issue 1 E50-E56, Copyright © 1992 by American Physiological Society

ARTICLES

Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation

J. J. Choo, M. A. Horan, R. A. Little and N. J. Rothwell
Department of Physiological Sciences, University of Manchester Medical School, United Kingdom.

The potent anabolic effects of the beta 2-adrenoceptor agonist clenbuterol on skeletal muscle have been reported to be independent of actions on beta-adrenoceptors. In the present study clenbuterol, presented to rats in the diet (4 mg/kg), caused significant increases in gastrocnemius muscle mass, protein, and RNA content and a decrease in epididymal fat pad mass. These effects were not mimicked by oral administration of the beta 2-adrenoceptor agonist salbutamol even at high dose (52 mg/kg diet), and the effects of clenbuterol were not inhibited by addition of DL-propranolol (200 mg/kg diet). However, the selective beta 2-antagonist ICI-118,551 (200 mg/kg diet) reversed the anabolic effects of clenbuterol, and a high dose of DL-propranolol (1,000 mg/kg diet) also inhibited these actions of clenbuterol. Furthermore, continuous infusion of salbutamol (1.15 mg.kg body wt-1.day-1) via miniosmotic pumps did cause significant increases in muscle mass, protein, and RNA content. These results indicate that the anabolic effects of clenbuterol are dependent on interaction with the beta 2-adrenoceptor. However, a long duration of action appears to be required to induce the anabolic effects of beta 2-agonists.

This article has been cited by other articles:

				J. G. Ryall, J. D. Schertzer, T. M. Alabakis, S. M. Gehrig, D. R. Plant, and G. S. Lynch Intramuscular {beta}2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury J Appl Physiol, July 1, 2008; 105(1): 165 - 172. [Abstract] [Full Text] [PDF]

				G. S. Lynch and J. G. Ryall Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease Physiol Rev, April 1, 2008; 88(2): 729 - 767. [Abstract] [Full Text] [PDF]

				F. Beitzel, M. N. Sillence, and G. S. Lynch beta-Adrenoceptor signaling in regenerating skeletal muscle after beta-agonist administration Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E932 - E940. [Abstract] [Full Text] [PDF]

				W. O. Kline, F. J. Panaro, H. Yang, and S. C. Bodine Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol J Appl Physiol, February 1, 2007; 102(2): 740 - 747. [Abstract] [Full Text] [PDF]

				B Le Panse, A Arlettaz, H Portier, A-M Lecoq, J De Ceaurriz, and K Collomp Short term salbutamol ingestion and supramaximal exercise in healthy women Br. J. Sports Med., July 1, 2006; 40(7): 627 - 631. [Abstract] [Full Text] [PDF]

				J. Caruso, J. Hamill, M. Yamauchi, D. Mercado, T. Cook, B. Higginson, S. O'Meara, J. Elias, and S. Siconolfi Albuterol aids resistance exercise in reducing unloading-induced ankle extensor strength losses J Appl Physiol, May 1, 2005; 98(5): 1705 - 1711. [Abstract] [Full Text] [PDF]

				F. Beitzel, P. Gregorevic, J. G. Ryall, D. R. Plant, M. N. Sillence, and G. S. Lynch {beta}2-Adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury J Appl Physiol, April 1, 2004; 96(4): 1385 - 1392. [Abstract] [Full Text] [PDF]

				J.-F. Desaphy, S. Pierno, A. De Luca, P. Didonna, and D. C. Camerino Different Ability of Clenbuterol and Salbutamol to Block Sodium Channels Predicts Their Therapeutic Use in Muscle Excitability Disorders Mol. Pharmacol., March 1, 2003; 63(3): 659 - 670. [Abstract] [Full Text] [PDF]

				J. G. Burniston, Y. Ng, W. A. Clark, J. Colyer, L.-B. Tan, and D. F. Goldspink Myotoxic effects of clenbuterol in the rat heart and soleus muscle J Appl Physiol, November 1, 2002; 93(5): 1824 - 1832. [Abstract] [Full Text] [PDF]

				W. N. Smith, A. Dirks, T. Sugiura, S. Muller, P. Scarpace, and S. K. Powers Alteration of contractile force and mass in the senescent diaphragm with beta 2-agonist treatment J Appl Physiol, March 1, 2002; 92(3): 941 - 948. [Abstract] [Full Text] [PDF]

				A. A. Sneddon, M. I. Delday, J. Steven, and C. A. Maltin Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70S6k in muscle showing clenbuterol-induced anabolism Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E676 - E682. [Abstract] [Full Text] [PDF]

				B. Polla, V. Cappelli, F. Morello, M. A. Pellegrino, F. Boschi, O. Pastoris, and C. Reggiani Effects of the {beta}2-agonist clenbuterol on respiratory and limb muscles of weaning rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R862 - R869. [Abstract] [Full Text] [PDF]

				L. C. C. Navegantes, N. M. Z. Resano, R. H. Migliorini, and I. C. Kettelhut Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E663 - E668. [Abstract] [Full Text] [PDF]

				K. D. Chen and S. E. Alway A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats J Appl Physiol, August 1, 2000; 89(2): 606 - 612. [Abstract] [Full Text] [PDF]

				P N R Dekhuijzen, H A Machiels, L M A Heunks, H F M van der Heijden, and R H H van Balkom Athletes and doping: effects of drugs on the respiratory system Thorax, November 1, 1999; 54(11): 1041 - 1046. [Full Text]

				P. E.M.H. Habets, D. Franco, J. M. Ruijter, A. J. Sargeant, J. A.A. Sant'Ana Pereira, and A. F.M. Moorman RNA Content Differs in Slow and Fast Muscle Fibers: Implications for Interpretation of Changes in Muscle Gene Expression J. Histochem. Cytochem., August 1, 1999; 47(8): 995 - 1004. [Abstract] [Full Text]

				Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease . A Statement of the American Thoracic Society and European Respiratory Society Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): S2 - 40. [Full Text] [PDF]

				H. F. M. Van Der Heijden, P. N. R Dekhuijzen, H. Folgering, L. A. Ginsel, and C. L. A. Van Herwaarden Long-term effects of clenbuterol on diaphragm morphology and contractile properties in emphysematous hamsters J Appl Physiol, July 1, 1998; 85(1): 215 - 222. [Abstract] [Full Text] [PDF]

				A. J. Bakker, S. I. Head, A. C. Wareham, and D. G. Stephenson Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibers Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1718 - C1726. [Abstract] [Full Text] [PDF]

				R. J. L. Murphy, P. F. Gardiner, G. Rousseau, M. Bouvier, and L. Beliveau Chronic beta -blockade increases skeletal muscle beta -adrenergicreceptor density and enhances contractile force J Appl Physiol, August 1, 1997; 83(2): 459 - 465. [Abstract] [Full Text] [PDF]